Atopaxar hydrochloride | CAS# 474544-83-7|

MedKoo Cat#: 593041 | Name: Atopaxar hydrochloride

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Atopaxar hydrochloride is used in the Treatment of Cardiovascular Disorders.

Chemical Structure

Atopaxar hydrochloride

CAS#474544-83-7 (HCl)

Theoretical Analysis

MedKoo Cat#: 593041

Name: Atopaxar hydrochloride

CAS#: 474544-83-7 (HCl)

Chemical Formula: C29H39ClFN3O5

Exact Mass: 0.0000

Molecular Weight: 564.10

Elemental Analysis: C, 61.75; H, 6.97; Cl, 6.28; F, 3.37; N, 7.45; O, 14.18

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

751475-53-3 (free base) 474550-69-1 (HBr) 474544-83-7 (HCl)

Synonym

Atopaxar hydrochloride; Atopaxar HCl; E5555 HCl; E 5555 HCl; E-5555 HCl

IUPAC/Chemical Name

1-(3-tert-butyl-4-methoxy-5-morpholin-4-ylphenyl)-2-(5,6-diethoxy-4-fluoro-3-imino-1H-isoindol-2-yl)ethanone;hydrochloride

InChi Key

DUUYZYAKJMJYJV-UHFFFAOYSA-N

InChi Code

InChI=1S/C29H38FN3O5.ClH/c1-7-37-23-15-19-16-33(28(31)24(19)25(30)27(23)38-8-2)17-22(34)18-13-20(29(3,4)5)26(35-6)21(14-18)32-9-11-36-12-10-32;/h13-15,31H,7-12,16-17H2,1-6H3;1H

SMILES Code

N=C1N(CC(C2=CC(N3CCOCC3)=C(OC)C(C(C)(C)C)=C2)=O)CC4=C1C(F)=C(OCC)C(OCC)=C4.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 564.10 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Klonaris C, Patelis N, Drebes A, Matheiken S, Liakakos T. Antiplatelet Treatment in Peripheral Arterial Disease: The Role of Novel Antiplatelet Agents. Curr Pharm Des. 2016;22(29):4610-4616. Review. PubMed PMID: 27281329. 2: Packard KA, Campbell JA, Knezevich JT, Davis EM. Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome. Pharmacotherapy. 2012 Mar;32(3):244-73. doi: 10.1002/j.1875-9114.2012.01021.x. Review. PubMed PMID: 22392457. 3: Siddique A, Butt M, Shantsila E, Lip GY. New antiplatelet drugs: beyond aspirin and clopidogrel. Int J Clin Pract. 2009 May;63(5):776-89. doi: 10.1111/j.1742-1241.2009.02058.x. Review. PubMed PMID: 19392926. 4: Postuła M, Akram S, Akram F. Current problems, new opportunities and future directions of anti-platelet therapy - increasing role of novel antiplatelet agents in cardiovascular diseases. Recent Pat Cardiovasc Drug Discov. 2009 Jan;4(1):55-60. Review. PubMed PMID: 19149707. 5: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Nov;29(9):625-55. PubMed PMID: 18193114.